WASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.
WASHINGTON (AP) – The U.S. on Tuesday recommended a "pause" in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of rare but potentially dangerous blood clots, setting off a chain reaction worldwide and dealing a setback to the global vaccine campaign.
LONDON (AP) – AstraZeneca reported today (March 22) that its COVID-19 vaccine provided strong protection among all adults in a long-anticipated U.S. study, raising hopes that the findings could help rebuild public confidence in the beleaguered shot in other countries and moving a step closer to clearance for American use.
WASHINGTON (AP) – The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday (Feb. 27) cleared a Johnson & Johnson shot that works with just one dose instead of two.
Johnson & Johnson's long-awaited vaccine appears to protect against COVID-19 with just one shot – not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses.
WASHINGTON (AP) — A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
The biggest vaccination campaign in U.S. history kicked off Monday (Dec. 14) as health workers rolled up their sleeves for shots to protect them from COVID-19 and start beating back the pandemic — a day of optimism even as the nation's death toll closed in on 300,000.
WASHINGTON (AP) — U.S. regulators Tuesday released their first scientific evaluation of Pfizer's COVID-19 vaccine and confirmed it offers strong protection, setting the stage for the government to green-light the biggest vaccination effort in the nation's history.
(AP) – Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection.
Pfizer said Friday (Nov. 20) it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic – but not until after a long, hard winter.